+1. Not bad indeed. Look at % revenue growth... demonstrates (local market) revenue generation doing well.
- Q4 FY20 Operating Revenue (up 31.4% from Q4 FY19) & (up 40.8% from Q3 FY20)
- Q4 FY20 Total Revenue (up 41.0% v Q4 FY19) & (up 99.8% vs Q3 FY20)
- FY20 Operating Revenue (up 17.0% from FY19)
- FY20 Total Revenue (up 20.8% from FY19)
Operating Costs Q4 FY20 $1.095m improved from Q3 FY20 $2.668m from better cost management, granted yes, a significant amount of it is boosted by government grants and incentives. This is operating steadily but agree... would love to see international revenues start contributing for this to fly. $MDR reporting Asia being on track to deliver revenue next quarter is promising. Keep watching.
- Forums
- ASX - By Stock
- Ann: MedAdvisor June 2020 Quarterly Activities Report
MDR
medadvisor limited
Add to My Watchlist
0.00%
!
8.0¢

+1. Not bad indeed. Look at % revenue growth... demonstrates...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.98M |
Open | High | Low | Value | Volume |
8.0¢ | 8.0¢ | 7.8¢ | $10.54K | 133.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 135000 | 7.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 7041 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 135000 | 0.077 |
3 | 336663 | 0.076 |
1 | 46500 | 0.075 |
2 | 100013 | 0.074 |
1 | 200000 | 0.073 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 7041 | 1 |
0.084 | 100951 | 1 |
0.088 | 75865 | 2 |
0.090 | 40000 | 1 |
0.091 | 100000 | 1 |
Last trade - 15.05pm 23/06/2025 (20 minute delay) ? |
Featured News
MDR (ASX) Chart |